Alterations of lipid profile are a well-known phenomenon in thyroid dysfunction. However,
little is known about the influence of thyroid hormone on Lp A-I and LpA-I:A-II particles.
We have, therefore, studied LpA-I and LpAI:A-II concentrations in a group of 20 patients
with hyperthyroidism and in a group of 15 patients with hypothyroidism before and
one month after attainment of euthyroidism. In hypothyroid patients, LDL-cholesterol
and apo B concentrations decrease significantly after L-T4 replacement treatment (from 4.49 ± 2.51 to 2.76 ± 0.70 mmol/L, P = 0.036 and from
89.4 ± 16.1 to 78.3 ± 13.3 mg/dL, P = 0.05, respectively), whereas no significant
change was observed in the total cholesterol, HDL-C, LpA-I, LpA-I:A-II and apo A-I
concentrations. In hyperthyroid patients, total cholesterol (from 3.58 ± 0.72 to 4.74
± 1.39 mmol/L, P = 0.0025), HDL-C (from 1.19 ± 0.23 to 1.41 ± 0.27 mmol/L, P = 0.0084),
LDL-C (from 1.83 ± 0.69 to 2.96 ± 1.20 mmol/l, P = 0.0025), apo A-I (from 85.6 ± 12.5
to 91.7 ± 18.1 mg/dL, P = 0.05) and apo B (from 52.7 ± 8.2 to 65.6 ± 16.5 mg/dL, P
= 0.0013) increased after restoration of euthyroidism while triglycerides, LpA-I and
LpA-I: A-II concentrations were unchanged. LpA-I and LpA-I:A-II concentrations were
not related to thyroid hormones in both groups. Our study suggests that LpA-I and
LpA-I:A-II particles are not under the direct control of thyroid hormones.
Key words
LpA-I, LpA-I:A-II - Thyroid Replacement - Propylthiouracil - Lipoproteins
